Entity Common Stock, Shares Outstanding of CERO THERAPEUTICS HOLDINGS, INC. from 01 Apr 2024 to 19 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CERO THERAPEUTICS HOLDINGS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Apr 2024 to 19 Nov 2025.
  • CERO THERAPEUTICS HOLDINGS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 19 Nov 2025 was 21,102,671, a 86% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CERO THERAPEUTICS HOLDINGS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 21,102,671 -129,209,901 -86% 19 Nov 2025 10-Q 19 Nov 2025 2025 Q3
Q3 2025 1,205,402 21 Aug 2025 10-Q 22 Aug 2025 2025 Q2
Q1 2025 5,380,723 -9,342,842 -63% 11 Apr 2025 10-K 15 Apr 2025 2024 FY
Q4 2024 150,312,572 19 Nov 2024 10-Q/A 20 Nov 2024 2024 Q3
Q2 2024 50,739,552 13 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 14,723,565 01 Apr 2024 10-K 02 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.